• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • James J Moon, Heikyung Suh, Mark E. Polhemus, Christian F. Ockenhouse, Anjali Yadava, Darrell J. Irvine
  • Biology, Medicine
  • PloS one
  • 2012 (First Published: 6 February 2012)
  • The parasite Plasmodium vivax is the most frequent cause of malaria outside of sub-Saharan Africa, but efforts to develop viable vaccines against P. vivax so far have been inadequate. We recentlyContinue Reading
  • Jason W. Bennett, Anjali Yadava, +23 authors Christian F. Ockenhouse
  • Biology, Medicine
  • PLoS neglected tropical diseases
  • 2016 (First Published: 26 February 2016)
  • BACKGROUND A vaccine to prevent infection and disease caused by Plasmodium vivax is needed both to reduce the morbidity caused by this parasite and as a key component in efforts to eradicate malariaContinue Reading
  • Sanjeev Kumar, Wilkie Collins, +6 authors David C Kaslow
  • Biology, Medicine
  • Infection and immunity
  • 2000 (First Published: 1 April 2000)
  • The immunogenicity and protective efficacy of four versions of recombinant C-terminal 19-kDa epidermal growth factor-like region of the major surface protein 1 (rMSP1(19)) of Plasmodium falciparumContinue Reading
  • Anjali Yadava, Christian F. Ockenhouse
  • Biology, Medicine
  • Infection and immunity
  • 2003 (First Published: 1 September 2003)
  • We have produced two synthetic genes that code for the F2 domain located within region II of the 175-kDa Plasmodium falciparum erythrocyte binding antigen (EBA-175) to determine the effects of codonContinue Reading
  • Anjali Yadava, Jetsumon Sattabongkot, +5 authors Christian F. Ockenhouse
  • Biology, Medicine
  • Infection and immunity
  • 2007 (First Published: 1 March 2007)
  • A successful vaccine against Plasmodium vivax malaria would significantly improve the health and quality of the lives of more than 1 billion people around the world. A subunit vaccine is the onlyContinue Reading
  • Joshua D. Hartzell, Naomi E. Aronson, Peter J. Weina, Robin S. Howard, Anjali Yadava, Glenn W Wortmann
  • Medicine
  • The American journal of tropical medicine and…
  • 2008 (First Published: 1 December 2008)
  • The rK39 test is a serologic assay for the rapid diagnosis of visceral leishmaniasis (VL). Serum from a North American cohort of 59 otherwise asymptomatic soldiers with cutaneous leishmaniasis (CL)Continue Reading
  • Kurt E. Schaecher, Sanjai Kumar, Anjali Yadava, Maryanne T. Vahey, Christian F. Ockenhouse
  • Biology, Medicine
  • Infection and immunity
  • 2005 (First Published: 1 September 2005)
  • High-density oligonucleotide microarrays are widely used to study gene expression in cells exposed to a variety of pathogens. This study addressed the global genome-wide transcriptional activation ofContinue Reading
  • Diego A Espinosa, Anjali Yadava, Evelina Angov, Paul L Maurizio, Christian F. Ockenhouse, Fidel P. Zavala
  • Biology, Medicine
  • Infection and immunity
  • 2013 (First Published: 1 August 2013)
  • The development of vaccine candidates against Plasmodium vivax-the most geographically widespread human malaria species-is challenged by technical difficulties, such as the lack of in vitro cultureContinue Reading